Elevated level of C-reactive protein is associated with risk of prediabetes in Indians

Atherosclerosis

Volumn 222, Issue 2, 2012, Pages 495-501

  Jaiswal, Alok ^a   Tabassum, Rubina ^a   Podder, Avijit ^a   Ghosh, Saurabh ^b   Tandon, Nikhil ^c   Bharadwaj, Dwaipayan ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b INDIAN STATISTICAL INSTITUTE   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

HsCRP; Impaired fasting glucose; Impaired glucose tolerance; Indians; Prediabetes

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UREA; URIC ACID;

ADULT; AGE; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FAMILY HISTORY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEMOGLOBIN BLOOD LEVEL; HIP; HOMEOSTASIS; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INDIAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INDIA; INFLAMMATION; INFLAMMATION MEDIATORS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDIABETIC STATE; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION;

EID: 84861349374     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.02.034     Document Type: Article

References (28)

1. Ramachandran A., Snehalatha C. Current scenario of diabetes in India. J Diab 2009, 1(1):18-28.
2. Ramachandran A., Snehalatha C., Kapur A., et al. High prevalence of diabetes and impaired glucose tolerance in India: national urban diabetes survey. Diabetologia 2001, 44(9):1094-1101.
3. McKeigue P.M., Shah B., Marmot M.G. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1998, 337(8738):382-386.
4. Bharadwaj D., Stein M.P., Volzer M., et al. The major receptor for C-reactive protein on leukocytes Is Fc(Receptor II). J Exp Med 1999, 190(4):585-590.
5. Bharadwaj D., Mold C., Markham E., et al. Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis. J Immunol 2001, 166(11):6735-6741.
6. Khera A., McGuire D.K., Murphy S.A., et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005, 46(3):464-469.
7. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J Clin Invest 2006, 116(8):1793-1801.
8. Sabanayagam C., Shankar A., Lim S.C., et al. Serum C-reactive protein level and prediabetes in two Asian populations. Diabetologia 2011, 54(4):767-775.
9. Mahajan A., Tabassum R., Chavali S., et al. High-sensitivity C-reactive protein levels and type 2 diabetes in urban North Indians. J Clin Endocrinol Metab 2009, 94(6):2123-2127.
10. Mahajan A., Jaiswal A., Tabassum R., et al. Elevated levels of C-reactive protein as a risk factor for metabolic syndrome in Indians. Atherosclerosis 2012, 220(1):275-281.
11. Genuth S., Alberti K.G., Bennett P., et al. Expert committee on the diagnosis and classification of diabetes mellitus: follow-up report on the diagnosis of diabetes mellitus. Diab Care 2003, 26(11):3160-3167.
12. Indian Diabetes Consortium. INDICO: the development of a resource for epigenomic study of Indians undergoing socioeconomic transition HUGO J 2011; 5:65-69.
13. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003; 26 Suppl 1:S5-S20.
14. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419.
15. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107(3):499-511.
16. Misra A., Chowbey P., Makkar B.M., et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India 2009, 57:163-170.
17. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-3421.
18. Ridker P.M., Hennekens C.H., Buring J.E., et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342(12). 836-483.
19. Kaptoge S., Di Angelantonio E., et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375(9709):132-140. Emerging Risk Factors Collaboration.
20. Doi Y., Kiyohara Y., Kubo M., et al. Relationship between C-reactive protein and glucose levels in community-dwelling subjects without diabetes: the Hisayama study. Diab Care 2005, 28(5):1211-1213.
21. de Rekeneire N., Peila R., Ding J., et al. Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study. Diab Care 2006, 29(8):1902-1908.
22. Lin J., Zhang M., Song F., et al. Association between C-reactive protein and pre-diabetic status in a Chinese Han clinical population. Diab Metab Res Rev 2009, 25(3):219-223.
23. Rydén L., Standl E., Bartnik M., et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007, 28(1):88-136.
24. Lee J., Heng D., Chia K.S., et al. Risk factors and incident coronary heart disease in Chinese, Malay and Asian Indian males: the Singapore Cardiovascular cohort study. Int J Epidemiol 2001, 30(5):983-988.
25. Dilley J., Ganesan A., Deepa R., et al. Association of A1C with cardiovascular disease and metabolic syndrome in Asian Indians with normal glucose tolerance. Diab Care 2007, 30(6):1527-1532.
26. Schwartz R., Osborne-Lawrence S., Hahner L., et al. C-reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice. Circ Res 2007, 100(10):1452-1459.
27. D'Alessandris C., Lauro R., Presta I., et al. C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport. Diabetologia 2007, 50(4):840-849.
28. Pravenec M., Kajiya T., Zídek V., et al. Effects of human C-reactive protein on pathogenesis of features of the metabolic syndrome. Hypertension 2011, 57(4):731-737.